Amica Mutual Insurance Co. lifted its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 327.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,202 shares of the semiconductor company’s stock after acquiring an additional 4,750 shares during the quarter. Amica Mutual Insurance Co.’s holdings in Synopsys were worth $3,060,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Stanley Laman Group Ltd. grew its stake in shares of Synopsys by 542.9% in the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after buying an additional 10,874 shares in the last quarter. Symphony Financial Ltd. Co. increased its stake in Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares during the period. Bank of New York Mellon Corp boosted its stake in Synopsys by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after buying an additional 4,815 shares in the last quarter. Waverton Investment Management Ltd lifted its stake in Synopsys by 15.0% during the second quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock worth $296,630,000 after purchasing an additional 75,374 shares during the period. Finally, Motley Fool Asset Management LLC lifted its holdings in shares of Synopsys by 13.4% during the second quarter. Motley Fool Asset Management LLC now owns 9,757 shares of the semiconductor company’s stock valued at $5,002,000 after acquiring an additional 1,156 shares during the period. Institutional investors own 85.47% of the company’s stock.
Insider Buying and Selling
In other news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 4,157 shares of company stock valued at $1,945,036. 0.62% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on Synopsys
Synopsys Stock Performance
Shares of NASDAQ:SNPS opened at $437.09 on Monday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The stock has a market capitalization of $83.62 billion, a price-to-earnings ratio of 54.70, a price-to-earnings-growth ratio of 3.64 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The company’s 50 day simple moving average is $477.13 and its 200 day simple moving average is $488.65.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.Synopsys’s quarterly revenue was up 37.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- America’s 1776 happening again
- Trump & Musk’s Secret Bet on Silver — Exposed
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
